C29H28F3NO12
Neat
639.53
N-Trifluoroacetyldoxorubicin; N-Trifluoroacetyladriamycin; 26295-56-7; AD-41; ITA96UBK4T; DTXSID10949158; NSC-283464; RefChem:927350; DTXCID501768824; NSC283464; AD41; orb1701851; SCHEMBL22566387; SCHEMBL29395359; AKOS040747228; 2, 2, 2-trifluoro-N-[(2S, 3S, 4S, 6R)-3-hydroxy-2-methyl-6-[[(1S, 3S)-3, 5, 12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6, 11-dioxo-2, 4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]acetamide; CS-0108244; Q27280887; 2, 2, 2-trifluoro-N-[(2S, 3S, 4S, 6R)-3-hydroxy-2-methyl-6-[[(1S, 3S)-3, 5, 12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6, 11-dioxo-2, 4-dihydro-1H-tetracen-1-yl]oxy]tetrahydropyran-4-yl]acetamide; 5, 12-NAPHTHACENEDIONE, 7, 8, 9, 10-TETRAHYDRO-6, 8, 11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-10-((2, 3, 6-TRIDEOXY-3-((2, 2, 2-TRIFLUOROACETYL)AMINO)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-, (8S and 10S)-
2, 2, 2-trifluoro-N-[(2S, 3S, 4S, 6R)-3-hydroxy-2-methyl-6-[[(1S, 3S)-3, 5, 12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6, 11-dioxo-2 and 4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]acetamide
InChI=1S/C29H28F3NO12/c1-10-22(36)13(33-27(41)29(30,31)32)6-17(44-10)45-15-8-28(42,16(35)9-34)7-12-19(15)26(40)21-20(24(12)38)23(37)11-4-3-5-14(43-2)18(11)25(21)39/h3-5,10,13,15,17,22,34,36,38,40,42H,6-9H2,1-2H3,(H,33,41)/t10-,13-,15-,17-,22+,28-/m0/s1